Psycheceutical Named a 2023 Top 10 Biotech Startup by Life Sciences Review
13 Apr 2023 //
PR NEWSWIRE
Psycheceutical Hosts Rick Doblin at Its Drug Development Lab
29 Mar 2023 //
GLOBENEWSWIRE
Psycheceutical Announces Research Results for NeuroDirect Ketamine Topical Cream
21 Mar 2023 //
GLOBENEWSWIRE
Psycheceutical to Conduct PI and II Trials of Ketamine Topical Cream for PTSD
15 Feb 2023 //
GLOBENEWSWIRE
Psycheceutical Announces Completion of Pre-IND Meeting with FDA for Ketamine
02 Feb 2023 //
GLOBENEWSWIRE
Psycheceutical Provisional Patent Application for Novel Ketamine Topical
26 Jan 2023 //
GLOBENEWSWIRE
Psycheceutical Announces Julian Bailes as Board Member and CMO
10 Jan 2023 //
GLOBENEWSWIRE
Dr. Aric Logsdon Joins Psycheceutical Bioscience, Inc. as Company’s Scientific Director
29 Nov 2022 //
GLOBENEWSWIRE
Psycheceutical Bioscience.`s Zappy Zapolin Added to The Benzinga Psychedelics
04 Oct 2022 //
GLOBENEWSWIRE
Psycheceutical Enters into Exclusive Option to Acquire Vici Health Sciences
16 Aug 2022 //
GLOBENEWSWIRE